Literature DB >> 11105422

Homocystinuria with congenital/developmental cataract.

K N Sulochana1, S Amirthalakshmi, S B Vasanthi, R Tamilselvi, S Ramakrishnan.   

Abstract

The aim of the study is to screen patients for homocystinuria with and without cataract and analyse for homocystine and methionine. Fifty-eight samples from 29 patients, i.e., plasma and urine collected after overnight fasting were analysed by the screening test for homocystine, and paper chromatography for homocystine and methionine. Out of 29 homocystinuric patients, 24 had cataract. Only one had appreciable amounts of methionine in his serum. He also had mental retardation as expected and belongs to Type I. The other types did not have methionine but had only homocystine. There was no mental retardation or ectopia lentis. So they belonged to Types II, III or IV. As there is excess methionine in Type I, with low cystine, cataract may be due to deficiency of cysteine and reduced glutathione and might be averted by suitable therapy, i.e., high cystine-low methionine diet with B6. In other types with low methionine, cataract may be due to decreased availability of amino acids for the synthesis of lens proteins; the treatment of choice should be B12, and folate with methionine.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11105422     DOI: 10.1007/bf02723928

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  8 in total

1.  High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum.

Authors:  B Vester; K Rasmussen
Journal:  Eur J Clin Chem Clin Biochem       Date:  1991-09

2.  Treatment of homocystinuria with a low-methionine diet, supplemental cystine, and a methyl donor.

Authors:  T L Perry; S Hansen; D L Love; L E Crawford; B Tischler
Journal:  Lancet       Date:  1968-08-31       Impact factor: 79.321

3.  Homocystinuria. At the North Carolina State School for the Blind.

Authors:  G D Presley; I N Stinson; J B Sidbury
Journal:  Am J Ophthalmol       Date:  1968-11       Impact factor: 5.258

4.  In vitro oxidation of ascorbic acid and its prevention by GSH.

Authors:  B S Winkler
Journal:  Biochim Biophys Acta       Date:  1987-09-11

5.  Pyridoxine treatment does not prevent homocystinemia after methionine loading in adult homocystinuria patients.

Authors:  G H Boers; A G Smals; J I Drayer; F J Trijbels; A I Leermakers; P W Kloppenborg
Journal:  Metabolism       Date:  1983-04       Impact factor: 8.694

6.  The natural history of homocystinuria due to cystathionine beta-synthase deficiency.

Authors:  S H Mudd; F Skovby; H L Levy; K D Pettigrew; B Wilcken; R E Pyeritz; G Andria; G H Boers; I L Bromberg; R Cerone
Journal:  Am J Hum Genet       Date:  1985-01       Impact factor: 11.025

7.  Does elevated glutathione protect the cell from H2O2 insult?

Authors:  A Spector; R R Huang; G M Wang; C Schmidt; G Z Yan; S Chifflet
Journal:  Exp Eye Res       Date:  1987-09       Impact factor: 3.467

8.  Activity of glutathione peroxidase and glutathione reductase in the human lens related to age.

Authors:  W B Rathbun; M G Bovis
Journal:  Curr Eye Res       Date:  1986-05       Impact factor: 2.424

  8 in total
  2 in total

1.  Age-related cataracts: homocysteine coupled endoplasmic reticulum stress and suppression of Nrf2-dependent antioxidant protection.

Authors:  Rajan Elanchezhian; Periyasamy Palsamy; Christian J Madson; David W Lynch; Toshimichi Shinohara
Journal:  Chem Biol Interact       Date:  2012-09-01       Impact factor: 5.192

2.  Congenital cataract: An ocular manifestation of classical homocystinuria.

Authors:  Neelam Saba; Saba Irshad
Journal:  Mol Genet Genomic Med       Date:  2021-08-02       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.